API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Size will Grow at CAGR of 6.5% through 2030

Your avatar
Healtcare
According to the report, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market was valued at US$ 2.3 Bn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030. The active pharmaceutical ingredient (API) production is a critical component of drug development and any substance or combination of substances used in a finished pharmaceutical product (FPP) is called active pharmaceutical ingredient (API). The market report includes Chondroitin Sulfate, Hyaluronic Acid and Pancreatin APIs. Finished dose of any drug is a combination of active pharmaceutical ingredients and excipients. Excipient is an inactive substance in a drug dose. Chondroitin sulfate is a dietary supplement and a vital part of cartilage, while hyaluronic acid is a major API used in therapeutic products used in osteoarthritis, skin problems, and cosmetic use. Chondroitin sulfate is also used as aqua feed product.
Read Report Overview -   https://www.transparencymarketresearch.com/api-chondroitin-sulfate-hyaluronic-acid-pancreatin-market.html 
North America dominated the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market in terms of revenue in 2019 and the trend is expected to continue during the forecast period.
Rise in Prevalence of Chronic Diseases to Drive Global Market
Increase in prevalence of chronic diseases such as osteoarthritis and gastric diseases across the world is the major factor boosting the growth of the global chondroitin sulfate, hyaluronic acid, and pancreatin market
Rise in clinical studies on different grade products used for treatment of different diseases also fuels the growth of global chondroitin sulfate, hyaluronic acid, and pancreatin market
In June 2017, IBSA Institut Biochimique SA carried out a new clinical trial called Chondroitin vs. Celecoxib vs. Placebo Trial (CONCEPT), which exhibited that pharmaceutical grade chondroitin sulfate is as effective as an anti-inflammatory drug (celecoxib) and superior to placebo for pain reduction and improvement of functional disability in patients with knee osteoarthritis
Moreover, surge in drug master file (DMF) filings by India and China-based companies and availability for multiple applications are other factors accelerating the growth of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market
Request Brochure – 
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78276 
Hyaluronic Acid to be Dominant Product
In terms of product, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market has been divided into chondroitin sulfate, hyaluronic acid, and pancreatin
The hyaluronic acid segment accounted for a major market share in terms of revenue in 2019 due to increase in geriatric population, which demands higher hyaluronic acid products for anti-aging solutions, launch of advanced products containing hyaluronic acid visco-supplements, and rise in prevalence of arthritis across the globe
Chondroitin sulfate dominated the market in terms of volume, owing to rise in prevalence of osteoarthritis & osteoporosis, increase in adoption of chondroitin sulfate as nutraceutical supplements, and surge in clinical trials for chondroitin sulfate for bone & joint health supplements and alternate sources for obtaining chondroitin sulphate
Request COVID Analysis on API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market – 
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78276 
Powder to be Promising Type
In terms of type, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market has been classified into pellets, powder, and others
The powder segment accounted for a major market share in 2019 and the trend is expected to continue during the forecast period
The powder segment is likely to expand at a higher CAGR from 2020 to 2030, owing to higher demand for powder form, excellent free-flow properties for final formulation, easy transportation, cost effectiveness, and large number of bulk suppliers
Pharmaceutical Companies to Hold Major Market Share
Based on end user, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market has been categorized into pharmaceutical companies, biotechnology companies, and others
Pharmaceutical companies dominated the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market in 2019, due to ongoing clinical trials by pharmaceutical companies and growing regulatory compliance
Request Customization on API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Report 
– https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78276 
North America to Dominate Global Market
In terms of region, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America accounted for a major share of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market in 2019, owing to rise in prevalence of osteoarthritis, larger cattle inventory source for APIs, presence of major companies for supplements, and ongoing clinical trials
According to the Osteoarthritis Action Alliance, an estimated 54.4 million adults in the U.S. are affected by some form of arthritis. Of these, osteoarthritis affects nearly 30.8 million adults.
The market in Asia Pacific is expected to expand at a higher CAGR from 2020 to 2030 due to increase in the geriatric population, higher production capacity of APIs with largest exporters in the world, low cost manufacturing, higher patient pool, and rise in awareness about different diseases & their treatments
Competition Landscape
The global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is fragmented in terms of number of players, with entry of several new players in the past few years. Key players in the global market include Summit Nutritionals International, Inc., Sioux Pharm, Inc., TSI Group Ltd., Shandong Runxin Biotechnology Co., Ltd., ZPD A/S, Pacific Rainbow International, Inc., SEIKAGAKU CORPORATION, Synutra, Inc., Bioiberica S.A.U., Newgen Biotech USA Inc., Nordmark Arrzneimittel GmbH & Co. KG, and Qingdao WanTuMing Biological Products Co., Ltd.
New products, technological development, strategic collaborations, and regulatory approval for different grade products are the major strategies adopted by major companies in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market
Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market: Segmentation
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market, by Product
Chondroitin Sulfate
Hyaluronic Acid
Natural
Synthetic
Pancreatin
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market, by Type
Pellets
Powder
Others
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market, by End User
Pharmaceutical Companies
Biotechnology Companies
Others
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Keep discovering on Mamby:

Healthcare
If you liked this post, you may also be interested in...
O
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments